B Trademark
Trademark Overview
On Wednesday, July 10, 2024, a trademark application was filed for B with the United States Patent and Trademark Office. The USPTO has given the B trademark a serial number of 98641751. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 6, 2025. This trademark is owned by Glaxo Group Limited. The B trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
General Information
| Serial Number | 98641751 |
| Word Mark | B |
| Filing Date | Wednesday, July 10, 2024 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, May 6, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 11, 2025 |
Trademark Statements
| Description of Mark | The mark consists of Stylized representation of a molecular structure in the shape of an incomplete letter "B" to the right of three square-like shapes adjacent to each arm of the letter "B," the top two shapes consisting of three rounded corners with the lower right corner comprising a right angle corner, and the lower square shape consisting of two rounded corners with the upper right corner and lower right corner each comprising right angle corners; the top square shape appearing in hot pink and the remainder of the mark in purple. |
| Goods and Services | Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders |
| Indication of Colors claimed | The color(s) purple and hot pink is/are claimed as a feature of the mark. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 10, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Glaxo Group Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Stevenage SG12NY
GB |
| Party Name | Glaxo Group Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Stevenage SG12NY
GB |
Trademark Events
| Event Date | Event Description |
| Friday, January 31, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, July 10, 2024 | NEW APPLICATION ENTERED |
| Friday, January 31, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, February 2, 2025 | ASSIGNED TO EXAMINER |
| Monday, February 17, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 5, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 11, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 11, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 6, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
